Impurity Profiling of VO659, VICO’s Antisense Oligonucleotide for the Treatment of PolyQ Diseases
Time: 11:30 am
day: Day One AM
Details:
- Case study looking into VO659 antisense oligonucleotide which is in clinical trials for Huntington’s Disease, SCA1 and SCA3
- Utilizing LC-UV-MS for impurity profiling
- Qualifying levels of impurities in oligo drugs
